{"nct_id":"NCT03976375","title":"Efficacy and Safety of Pembrolizumab (MK-3475) With Lenvatinib (E7080/MK-7902) vs. Docetaxel in Participants With Metastatic Non-Small Cell Lung Cancer (NSCLC) and Progressive Disease (PD) After Platinum Doublet Chemotherapy and Immunotherapy (MK-7902-008/E7080-G000-316/LEAP-008)","status":"COMPLETED","status_verified_date":"2025-07","start_date":"2019-06-26","start_date_type":"ACTUAL","primary_completion_date":"2023-08-11","primary_completion_date_type":"ACTUAL","completion_date":"2024-08-22","completion_date_type":"ACTUAL","phases":["PHASE3"],"tickers":["MRK"]}